Highbridge Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Highbridge Capital Management’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	–	–	292
2024 Q2	–	Hold	0	–	–	–	216
2024 Q1	–	Hold	0	–	–	–	200
2023 Q4	–	Hold	0	–	–	–	185
2023 Q3	–	Hold	0	–	–	–	153
2023 Q2	–	Hold	0	–	–	–	229
2023 Q1	–	Hold	0	–	–	–	405
2022 Q4	–	Hold	0	–	–	–	451
2022 Q2	–	Hold	0	–	–	–	693
2022 Q1	–	Hold	0	–	–	–	509
2021 Q4	–	Hold	0	–	–	–	453

Other funds holding CLDI.WS

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Nomura Holdings

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return